✦ LIBER ✦

Phase II trial of fludarabine phosphate for adenocarcinoma of the pancreas

✍ Scribed by Lary J. Kilton; Al B. Benson; Alice Greenberg; Patricia Johnson; Charles Shapiro; Richard Blough; Suzanne French; Linda Weidner

Publisher: Springer US
Year: 1992
Tongue: English
Weight: 235 KB
Volume: 10
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00877246

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of fludarabine phosphate

Phase II study of fludarabine phosphate for gastric adenocarcinoma

✍ Lary J. Kilton; Julia B. Ashenhurst; James L. Wade; Richard L. Schilsky; Gail Sh 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 234 KB

A phase II trial of piroxantrone in aden

A phase II trial of piroxantrone in adenocarcinoma of the pancreas

✍ Terry R. Jenkins; Catherine Tangen; John S. Macdonald; Geoffrey Weiss; Robert Ch 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 180 KB

Phase II trial of topotecan in advanced

Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas

✍ Richard M. Scher; Richard Kosierowski; Charles Lusch; Roland Alexander; Stephen 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 631 KB

Phase II trial of gemcitabine (2,2′-difi

Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

✍ Ephraim S. Casper; Mark R. Green; David P. Kelsen; Robert T. Heelan; Thomas D. B 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 485 KB

Phase I clinical trial of fludarabine ph

Phase I clinical trial of fludarabine phosphate (F-ara-AMP)

✍ Ephraim S. Casper; Abraham Mittelman; David Kelson; Charles W. Young 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 335 KB

Phase II trial of fludarabine phosphate

Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced breast cancer

✍ A. Mittelman; R. Ashikari; T. Ahmed; S. Savona; P. Arnold; Z. Arlin 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 181 KB

Eighteen patients with advanced breast cancer were entered into a phase II study of fludarabine phosphate. Fludarabine phosphate was given by continuous infusion for 5 days, at a starting dose of 20 mg/m2 per day for patients previously treated with two or more regimens and 25 mg/m2 per day for mini